Bragg Gaming Announces Select Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results, and Issues Full Year 2026 Guidance
TORONTO–(BUSINESS WIRE)–Bragg Gaming Group (NASDAQ: BRAG, TSX: BRAG) (“Bragg” or the “Company”), a leading iGaming content and technology solutions... Read more.
Aalyria Raises $100 Million to Build the Next-Generation Communications Backbone of the New Space Age
Series B led by Battery Ventures and J2 Ventures to scale Aalyria’s Spacetime orchestration platform and Tightbeam optical technology – enabling adaptive, high-throughput... Read more.
Hurricane Electric Expands Network in Toronto With New Points of Presence at Two Telehouse Facilities
Deployments strengthen connectivity across Canada’s largest digital infrastructure hub and bring Hurricane Electric’s Toronto footprint to seven locations TORONTO–(BUSINESS... Read more.
Harvest Commercial Capital Merges with Crossroads Impact Corp. to Expand Small Business and Community Lending
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Harvest Commercial Capital, LLC (HCC), a leading nationwide originator of owner-occupied small business real estate... Read more.
Alto Neuroscience Announces Participation in Upcoming Investor Conferences
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–$anro #cns–Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused... Read more.
Rural Hospitals Select MEDITECH Expanse to Stay Independent Amidst Challenging Landscape
15 rural hospitals sign for Expanse in 2025, maintaining community-focused care CANTON, Mass.–(BUSINESS WIRE)–Facing a challenging market defined by... Read more.
Ladder Closes $675 Million in New Unsecured Capital Commitments, Including Expansion of Revolver Capacity to $1.25 Billion
NEW YORK–(BUSINESS WIRE)–Ladder Capital Corp (“Ladder,” the “Company,” “we” or “our”) (NYSE: LADR), a leading, investment grade-rated... Read more.
CI&T To Announce Fourth Quarter 2025 Results on March 11, 2026
NEW YORK–(BUSINESS WIRE)–CI&T (NYSE: CINT, “Company”), a global partner in tech-integrated business solutions, announces that it will report... Read more.
Angelini Pharma and Quiver Bioscience Announce Strategic Research Collaboration and Licensing Agreement to Discover and Advance Novel Therapeutics for Genetic Epilepsies
Angelini Pharma secures exclusive global license rights to future identified drug targets Quiver receives undisclosed advance payment and is eligible for future... Read more.
INSERTING and REPLACING GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026
Reported fourth quarter 2025 revenues of $121.0 million with 32% year-over-year growth in exome and genome test revenue (42% excluding a one-time 2024 benefit) Accelerated... Read more.